Neuromodulation for Refractory Neuropsychiatric and Pain Disorders
Course Overview
This course will provide an overview of neuromodulation therapy for neuropsychiatric diseases and conditions and will examine the potential short- and long-term benefits and risks; clinical indications; patient selection; and potential ethical issues associated with neuromodulation therapies, including their non-therapeutic use for cognitive and performance enhancement. Refractory psychiatric disorders are emphasized, as several psychiatric disorders are poorly responsive to standard therapies, leaving patients distressed and functionally impaired. Neuromodulation therapies (aside from ECT for refractory major depressive disorder) are a more recent option for psychiatric disorders, a rapidly growing indication for use. Refractory chronic pain is another therapeutic area discussed in this course.
Learning Outcomes
Upon the completion of this course, the learner should be able to:
- Outline the background and underlying concepts supporting neuromodulation therapy.
- Describe the mechanisms, benefits, and risks of electroconvulsive therapy (ECT).
- Review the implementation of transcranial magnetic and electric stimulation in psychiatric disorders.
- Evaluate the use of neuromodulation approaches to the management of treatment-refractory major depression disorder (MDD).
- Compare the efficacy of neuromodulation techniques for the treatment of other psychiatric disorders.
- Analyze the efficacy and safety of invasive neurostimulation for the management of psychiatric disorders.
- Formulate strategies for integrating neuromodulation therapies into comprehensive treatment plans for refractory pain conditions.
- Discuss the potential role of invasive neurostimulation in patients with chronic pain.
About the Author/Presenter
Mark Rose, BS, MA, LP, is a licensed psychologist in the State of Minnesota with a private consulting practice and a medical research analyst with a biomedical communications firm. Earlier healthcare technology assessment work led to medical device and pharmaceutical sector experience in new product development involving cancer ablative devices and pain therapeutics. Along with substantial experience in addiction research, Mr. Rose has contributed to the authorship of numerous papers on CNS, oncology, and other medical disorders. He is the lead author of papers published in peer-reviewed addiction, psychiatry, and pain medicine journals and has written books on prescription opioids and alcoholism published by the Hazelden Foundation. He also serves as an Expert Advisor and Expert Witness to law firms that represent disability claimants or criminal defendants on cases related to chronic pain, psychiatric/substance use disorders, and acute pharmacologic/toxicologic effects. Mr. Rose is on the Board of Directors of the Minneapolis-based International Institute of Anti-Aging Medicine and is a member of several professional organizations.
Audience/Accreditations and Approvals
TRC Healthcare/ NetCE
In support of improving patient care, this activity has been planned and implemented by TRC Healthcare/ NetCE. TRC Healthcare/NetCE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This course is designed for the following healthcare professions (select your profession for details):
Nursing, Physician
If you require special accommodations, please contact Colibri Healthcare Support by clicking here: Contact Us
